Pain is not a game. Chronic non-malignant pain has few effective treatment options, particularly since the adverse effects of opioids have become more known. Many patients with chronic pain also develop mental health issues such as depression and anxiety.  A new virtual reality system, designed for at-home self-use, has been approved by the FDA to treat chronic low back pain in adults.  Dr. John Swegle, a pain management expert, joins host Geoff Wall to discuss how this potentially gamechanging device gained FDA approval and logistical challenges patients may have in obtaining access.

Guest: 
John Swegle, PharmD, BCPS, BCACP
Clinical Associate Professor
University of Iowa College of Pharmacy

Redeem your CPE or CME credit here!

• Pharmacist members
• CME

Need a membership?

• Join for CPE Credit 
• Join for CME Credit 

References and Resources:
FDA Authorizes Marketing of Virtual Reality System for Chronic Pain Reduction: https://www.fda.gov/news-events/press-announcements/fda-authorizes-marketing-virtual-reality-system-chronic-pain-reduction
Virtual Reality Trial Using EaseVRx for Chronic Low Back Pain: https://clinicaltrials.gov/ct2/show/NCT04415177

Continuing Education Information:

Learning Objectives: 

1. Describe the purported mechanism of benefit of a virtual reality system in patients with low back pain
2. Discuss the study that supported a virtual reality device to receive FDA approval for pain management and its implications for patients with low back pain

Dr. John Swegle reports no actual or potential conflicts of interest associated with this episode.

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-039-H01-P
Initial release date: 01/03/22
Expiration date: 01/03/2023
Additional CPE & CME details can be found here

Follow CEimpact on Social Media:
LinkedIn
Instagram